Quarterly report pursuant to Section 13 or 15(d)

Note 2 - Liquidity (Details Textual)

v3.23.3
Note 2 - Liquidity (Details Textual) - USD ($)
Jun. 14, 2023
Apr. 10, 2023
Aug. 30, 2022
Aug. 11, 2022
Apr. 02, 2018
Mar. 03, 2017
Sep. 30, 2023
Mar. 31, 2023
Oct. 11, 2022
Sep. 30, 2022
The Business [Member]                    
Proceeds from Divestiture of Businesses   $ 250,000                
Disposal Group, Including Discontinued Operation, Consideration Receivable Within 60 Days After Closing Date   $ 500,000                
Sale of Assets to Cardinal Health 414 [Member]                    
Proceeds from Sale of Productive Assets $ 7,500,000       $ 6,000,000.0 $ 80,600,000        
API Development Funding and Access Agreement [Member]                    
Development Agreement, Reimbursement Amount             $ 1,850,000      
Development Agreement, Reimbursement Proceeds       $ 800,000            
CRG Loan Agreement, Texas Case [Member]                    
Litigation Settlement, Amount Awarded to Other Party     $ 2,600,000              
Loss Contingencies, Interest Rate             5.00% 18.00% 5.00% 18.00%
Loss Contingency Accrual             $ 2,711,806